News | January 15, 2015

Society of Interventional Radiology Launches New Brand Reinforcing Commitment to Develop New Treatments

New branding designed to enhance medical practice and improve standard of patient care through image-guided therapies

January 15, 2015 — The Society of Interventional Radiology (SIR) unveiled a new brand for the society and its research organization, the SIR Foundation. The new logos for both organizations convey the limitless possibilities of image-guided therapies to solve the toughest medical problems. SIR’s new tagline, “The vision to heal,” reflects the innovative, patient-driven care that board-certified interventional radiologists deliver through methods that result in less risk, less pain and shorter recovery time than traditional surgery.

“Interventional radiology showcases the very best of today’s medicine, bringing together clinical insight, procedural expertise and advanced image-guided technology to deliver high-quality patient care,” said SIR President James B. Spies, M.D., MPH, FSIR. “Our efforts reinforce how SIR continues to support our members as they deliver outstanding clinical care and how we will continue to do so in the years to come,” added Spies.

With the renewed focus on cost-effective, patient-driven care in the evolving healthcare landscape, SIR and SIR Foundation actively reaffirm interventional radiology’s role as part of the greater care team. Through the new brand, the society strengthens its identity, promoting the value that interventional radiology delivers — the same value being called for in medicine: better outcomes, less burden on the patient and innovative use of technology with clear patient benefit, noted Spies.

“Our new brand helps us to better communicate the valuable and unique role that interventional radiology has in delivering comprehensive clinical care,” said SIR Executive Director Susan E. Sedory Holzer, M.A., CAE. “By listening to our members, this new framework also reflects the passion and dedication members have for the specialty and, more importantly, high-quality care,” added Holzer.

For more information: www.sirweb.org

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init